Juan Carlos
Martínez Castrillo
Profesor/a Asociado/a en CC. de la Salud
Hospital Universitario San Cecilio
Granada, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario San Cecilio (8)
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
-
Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review
European Journal of Neurology, Vol. 28, Núm. 4, pp. 1188-1197
2019
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863
2018
-
Mitos y evidencias en el empleo de la toxina botulínica: Neurofarmacología y distonías
Revista de Neurologia, Vol. 66, Núm. 5, pp. 163-172
2014
-
BDNF Val66Met polymorphism in primary adult-onset dystonia: A case-control study and meta-analysis
Movement Disorders, Vol. 29, Núm. 8, pp. 1083-1086
-
Lack of validation of variants associated with cervical dystonia risk: A GWAS replication study
Movement Disorders, Vol. 29, Núm. 14, pp. 1825-1828
2012
-
levodopa en el tratamiento de la enfermedad de parkinson: Mitos y realidades
Revista de Neurologia, Vol. 55, Núm. 11, pp. 669-688